Clinical Trials


The Marcus Center for Cellular Cures (MC3) seeks to develop transformative clinical therapies using cells, tissues, molecules, genes, and biomaterials to treat diseases and injuries that currently lack effective treatments.

Current and potential future clinical trials include treatment for autism and related neurodevelopmental disorders, cerebral palsy, stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, arthritis and joint diseases, and chronic pulmonary diseases.